Inhibition of L-Type Ca 1.2 Ca Channels by 2,(4-Morpholinyl)-8-phenyl-4 -1-benzopyran-4-one (LY294002) and 2-[1-(3-Dimethyl-aminopropyl)-5-methoxyindol-3-yl]-3-(1 -indol-3-yl) Maleimide (Gö6983)
Welling A, Hofmann F, Wegener J (2005)
Molecular Pharmacology 67(2): 541-544.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Welling, A.;
Hofmann, F.;
Wegener, JörgUniBi
Abstract / Bemerkung
Phosphatidylinositol 3-kinase (PI3-K) is involved in physiological processes of cellular proliferation and inflammation and, as postulated recently, in the regulation of L-type Ca2+ channels. The latter conclusion arose in part from the inhibitory action of the compound 2,(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002), which has been established as a selective PI3-K inhibitor (IC50 = 1.4 μM). Herein we show, however, that LY294002 and an inhibitor of protein kinase C (PKC), 2-[1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl]-3-(1H-indol-3-yl) maleimide (Gö6983), act as direct Ca2+-channel inhibitors, with IC50 values of approximately 20 and 10 μM, respectively. Because both drugs are commonly used at concentrations of approximately 10 μM or higher, the interpretation of such experiments is questionable with respect to a regulatory action of PI3-K or PKC on L-type Ca2+ channels.
Erscheinungsjahr
2005
Zeitschriftentitel
Molecular Pharmacology
Band
67
Ausgabe
2
Seite(n)
541-544
ISSN
0026-895X
eISSN
1521-0111
Page URI
https://pub.uni-bielefeld.de/record/2984496
Zitieren
Welling A, Hofmann F, Wegener J. Inhibition of L-Type Ca 1.2 Ca Channels by 2,(4-Morpholinyl)-8-phenyl-4 -1-benzopyran-4-one (LY294002) and 2-[1-(3-Dimethyl-aminopropyl)-5-methoxyindol-3-yl]-3-(1 -indol-3-yl) Maleimide (Gö6983). Molecular Pharmacology. 2005;67(2):541-544.
Welling, A., Hofmann, F., & Wegener, J. (2005). Inhibition of L-Type Ca 1.2 Ca Channels by 2,(4-Morpholinyl)-8-phenyl-4 -1-benzopyran-4-one (LY294002) and 2-[1-(3-Dimethyl-aminopropyl)-5-methoxyindol-3-yl]-3-(1 -indol-3-yl) Maleimide (Gö6983). Molecular Pharmacology, 67(2), 541-544. https://doi.org/10.1124/mol.104.006049
Welling, A., Hofmann, F., and Wegener, Jörg. 2005. “Inhibition of L-Type Ca 1.2 Ca Channels by 2,(4-Morpholinyl)-8-phenyl-4 -1-benzopyran-4-one (LY294002) and 2-[1-(3-Dimethyl-aminopropyl)-5-methoxyindol-3-yl]-3-(1 -indol-3-yl) Maleimide (Gö6983)”. Molecular Pharmacology 67 (2): 541-544.
Welling, A., Hofmann, F., and Wegener, J. (2005). Inhibition of L-Type Ca 1.2 Ca Channels by 2,(4-Morpholinyl)-8-phenyl-4 -1-benzopyran-4-one (LY294002) and 2-[1-(3-Dimethyl-aminopropyl)-5-methoxyindol-3-yl]-3-(1 -indol-3-yl) Maleimide (Gö6983). Molecular Pharmacology 67, 541-544.
Welling, A., Hofmann, F., & Wegener, J., 2005. Inhibition of L-Type Ca 1.2 Ca Channels by 2,(4-Morpholinyl)-8-phenyl-4 -1-benzopyran-4-one (LY294002) and 2-[1-(3-Dimethyl-aminopropyl)-5-methoxyindol-3-yl]-3-(1 -indol-3-yl) Maleimide (Gö6983). Molecular Pharmacology, 67(2), p 541-544.
A. Welling, F. Hofmann, and J. Wegener, “Inhibition of L-Type Ca 1.2 Ca Channels by 2,(4-Morpholinyl)-8-phenyl-4 -1-benzopyran-4-one (LY294002) and 2-[1-(3-Dimethyl-aminopropyl)-5-methoxyindol-3-yl]-3-(1 -indol-3-yl) Maleimide (Gö6983)”, Molecular Pharmacology, vol. 67, 2005, pp. 541-544.
Welling, A., Hofmann, F., Wegener, J.: Inhibition of L-Type Ca 1.2 Ca Channels by 2,(4-Morpholinyl)-8-phenyl-4 -1-benzopyran-4-one (LY294002) and 2-[1-(3-Dimethyl-aminopropyl)-5-methoxyindol-3-yl]-3-(1 -indol-3-yl) Maleimide (Gö6983). Molecular Pharmacology. 67, 541-544 (2005).
Welling, A., Hofmann, F., and Wegener, Jörg. “Inhibition of L-Type Ca 1.2 Ca Channels by 2,(4-Morpholinyl)-8-phenyl-4 -1-benzopyran-4-one (LY294002) and 2-[1-(3-Dimethyl-aminopropyl)-5-methoxyindol-3-yl]-3-(1 -indol-3-yl) Maleimide (Gö6983)”. Molecular Pharmacology 67.2 (2005): 541-544.